Dark Forest Capital Management LP Invests $596,000 in ICU Medical, Inc. (NASDAQ:ICUI)

Dark Forest Capital Management LP bought a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) during the 4th quarter, Holdings Channel reports. The institutional investor bought 3,844 shares of the medical instruments supplier’s stock, valued at approximately $596,000.

Several other institutional investors have also recently added to or reduced their stakes in ICUI. Norges Bank purchased a new stake in ICU Medical in the fourth quarter valued at $40,151,000. Dimensional Fund Advisors LP lifted its holdings in shares of ICU Medical by 18.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock valued at $83,788,000 after purchasing an additional 82,982 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of ICU Medical in the 4th quarter valued at about $10,003,000. JPMorgan Chase & Co. grew its stake in ICU Medical by 7.4% during the 4th quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier’s stock worth $109,920,000 after buying an additional 49,108 shares during the last quarter. Finally, Proficio Capital Partners LLC acquired a new position in ICU Medical during the fourth quarter worth approximately $5,779,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ICUI. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. KeyCorp lowered their price objective on shares of ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. Finally, StockNews.com lowered ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $162.67.

ICU Medical Stock Performance

NASDAQ:ICUI opened at $135.66 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm has a market cap of $3.33 billion, a price-to-earnings ratio of -29.68 and a beta of 0.86. The firm’s fifty day moving average price is $143.81 and its 200 day moving average price is $158.23. ICU Medical, Inc. has a 1-year low of $94.19 and a 1-year high of $196.26.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.